Chronic Lymphocytic Leukemia in the Real World: Challenges of Managing the Older Patient

This information was originally presented on September 14, 2012, at the NCCN 7th Annual Congress: Hematologic Malignancies™ held in New York, New York.

Target Audience

This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.

Learning Objectives

Following this activity, participants should be able to:

  • Summarize the potential treatment challenges of older patients with CLL
  • Review current NCCN standards of care for older patients (or those with comorbid conditions) with CLL
  • Discuss the recent clinical trial data with new combination regimens or investigational agents, with a focus on older patients with CLL
Additional information
Supporters: 

Supported by educational grants from Genentech; Millennium: The Takeda Oncology Company; Novartis Pharmaceuticals Corporation; Otsuka America Pharmaceutical, Inc.; and sanofi-aventis U.S.

Course summary
Available credit: 
  • 0.50 Participation
  • 0.60 Nurse
  • 0.50 Pharmacist
  • 0.50 Physician
Course opens: 
11/09/2012
Course expires: 
11/09/2013
Cost:
$0.00

William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

Available Credit

  • 0.50 Participation
  • 0.60 Nurse
  • 0.50 Pharmacist
  • 0.50 Physician

Accreditation Period

Course opens: 
11/09/2012
Course expires: 
11/09/2013

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
  • Adobe Reader for certificate viewing/printing